TARDBP and Alzheimer disease: Immunohistochemical analysis of TDP-43 in pathologically confirmed cases demonstrated it in DLB/AD+ (31.3%), PD (7.2%), and PDD (19%), while DLB and normal controls exhibited none, and only one case presented TDP-43 pathology, respectively [34].